15-78593856-C-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_000745.4(CHRNA5):​c.*603C>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.241 in 151,890 control chromosomes in the GnomAD database, including 5,785 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.24 ( 5783 hom., cov: 32)
Exomes 𝑓: 0.20 ( 2 hom. )

Consequence

CHRNA5
NM_000745.4 3_prime_UTR

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -1.75

Publications

20 publications found
Variant links:
Genes affected
CHRNA5 (HGNC:1959): (cholinergic receptor nicotinic alpha 5 subunit) The protein encoded by this gene is a nicotinic acetylcholine receptor subunit and a member of a superfamily of ligand-gated ion channels that mediate fast signal transmission at synapses. These receptors are thought to be heteropentamers composed of separate but similar subunits. Defects in this gene have been linked to susceptibility to lung cancer type 2 (LNCR2).[provided by RefSeq, Jun 2010]
CHRNA3 (HGNC:1957): (cholinergic receptor nicotinic alpha 3 subunit) This locus encodes a member of the nicotinic acetylcholine receptor family of proteins. Members of this family of proteins form pentameric complexes comprised of both alpha and beta subunits. This locus encodes an alpha-type subunit, as it contains characteristic adjacent cysteine residues. The encoded protein is a ligand-gated ion channel that likely plays a role in neurotransmission. Polymorphisms in this gene have been associated with an increased risk of smoking initiation and an increased susceptibility to lung cancer. Alternatively spliced transcript variants have been described. [provided by RefSeq, Nov 2009]
CHRNA3 Gene-Disease associations (from GenCC):
  • urinary bladder, atony of
    Inheritance: AR Classification: STRONG Submitted by: Ambry Genetics, G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.95).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.343 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CHRNA5NM_000745.4 linkc.*603C>T 3_prime_UTR_variant Exon 6 of 6 ENST00000299565.9 NP_000736.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CHRNA5ENST00000299565.9 linkc.*603C>T 3_prime_UTR_variant Exon 6 of 6 1 NM_000745.4 ENSP00000299565.5

Frequencies

GnomAD3 genomes
AF:
0.241
AC:
36526
AN:
151708
Hom.:
5783
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0596
Gnomad AMI
AF:
0.408
Gnomad AMR
AF:
0.227
Gnomad ASJ
AF:
0.375
Gnomad EAS
AF:
0.0325
Gnomad SAS
AF:
0.219
Gnomad FIN
AF:
0.327
Gnomad MID
AF:
0.408
Gnomad NFE
AF:
0.347
Gnomad OTH
AF:
0.275
GnomAD4 exome
AF:
0.203
AC:
13
AN:
64
Hom.:
2
Cov.:
0
AF XY:
0.207
AC XY:
12
AN XY:
58
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
2
American (AMR)
AF:
0.00
AC:
0
AN:
2
Ashkenazi Jewish (ASJ)
AF:
0.500
AC:
1
AN:
2
East Asian (EAS)
AF:
0.00
AC:
0
AN:
4
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AC:
0
AN:
0
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
0.231
AC:
12
AN:
52
Other (OTH)
AF:
0.00
AC:
0
AN:
2
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
AF:
0.241
AC:
36526
AN:
151826
Hom.:
5783
Cov.:
32
AF XY:
0.238
AC XY:
17647
AN XY:
74184
show subpopulations
African (AFR)
AF:
0.0594
AC:
2455
AN:
41328
American (AMR)
AF:
0.226
AC:
3457
AN:
15268
Ashkenazi Jewish (ASJ)
AF:
0.375
AC:
1300
AN:
3470
East Asian (EAS)
AF:
0.0328
AC:
169
AN:
5158
South Asian (SAS)
AF:
0.221
AC:
1065
AN:
4820
European-Finnish (FIN)
AF:
0.327
AC:
3439
AN:
10518
Middle Eastern (MID)
AF:
0.401
AC:
118
AN:
294
European-Non Finnish (NFE)
AF:
0.347
AC:
23576
AN:
67952
Other (OTH)
AF:
0.273
AC:
576
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1270
2540
3810
5080
6350
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
370
740
1110
1480
1850
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.199
Hom.:
823
Bravo
AF:
0.224
Asia WGS
AF:
0.114
AC:
400
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.95
CADD
Benign
1.1
DANN
Benign
0.71
PhyloP100
-1.7
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs8192482; hg19: chr15-78886198; API